10-K Decoder · All companies

4D Molecular Therapeutics, Inc.

FDMT · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$85.2M$40K+212,925%
Operating income−$160M−$188M+15.1%
Net income−$140M−$161M+12.9%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 12, 2026

$Q3 2026Year earlierChange
Revenue$4.10M$100K+4,000%
Operating income−$81.2M−$61.2M−32.7%
Net income−$78.1M−$56.9M−37.3%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was 4D Molecular's revenue in FY2025?
$85.2M in FY2025 (Fiscal year ended Dec 31, 2025), +212,925% vs $40K a year earlier, per its 10-K filed Mar 2026.
Was 4D Molecular profitable in FY2025?
No: net income was −$140M and operating income −$160M in FY2025.
What was 4D Molecular's revenue in Q3 2026?
$4.10M (+4,000% vs a year earlier), per its Form 10-Q filed Nov 12, 2026.